Childhood Asthma and Smoking: Moderating Effect of Preterm Status and Birth Weight

Chukwuemeka E Ogbu1, Stella C Ogbu2, Dibya Khadka3

  • 1College of Public Health, University of South Florida, Tampa, USA.

Cureus
|May 21, 2021
PubMed

Insights

Parental smoking increases childhood asthma risk, especially in premature children. Birth weight and prematurity status significantly modify this association, highlighting the need for targeted interventions.

Area of Science:

  • Pediatric Pulmonology
  • Environmental Health
  • Epidemiology

Background:

  • Childhood asthma is a significant public health concern.
  • Parental smoking and secondhand smoke exposure are known risk factors for childhood asthma.
  • The moderating role of birth weight and prematurity (BWP) status on this association remains underexplored.

Purpose of the Study:

  • To examine the association between secondhand smoke exposure and childhood asthma.
  • To investigate the modifying effect of BWP status on the relationship between parental smoking and childhood asthma.
  • To evaluate the impact of secondhand smoke on asthma severity in children.

Main Methods:

  • Utilized data from 36,954 children aged 6-17 from the National Survey of Children's Health (2017-2018).
  • Employed logistic and multinomial regression models to assess secondhand smoke exposure and asthma association and severity.
  • Tested for interaction between parental smoking and BWP status.

Main Results:

  • Children exposed to indoor (AOR, 1.46) and outdoor (AOR, 1.27) parental smoking showed higher odds of asthma.
  • The association between parental smoking and asthma was significantly modified by BWP status.
  • Premature children with normal birth weight had the highest odds of asthma (AOR, 2.15); premature children with low birth weight had higher odds of mild (AOR, 1.90) and moderate/severe (AOR, 1.81) asthma.

Conclusions:

  • Birth weight and prematurity status are crucial moderators in the association between parental smoking and childhood asthma.
  • Asthma interventions should consider BWP status alongside parental smoking and smoke exposure.
  • Addressing these factors can help reduce childhood asthma morbidity and mortality.

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.9K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.5K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
901
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
610
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.8K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.8K